470 related articles for article (PubMed ID: 19181773)
1. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
[TBL] [Abstract][Full Text] [Related]
2. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging.
Donmez FY; Aslan H; Coskun M
Acta Radiol; 2009 Apr; 50(3):334-9. PubMed ID: 19235577
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
5. The role of quantitative neuroimaging indices in the differentiation of ischemia from demyelination: an analytical study with case presentation.
Hoque R; Ledbetter C; Gonzalez-Toledo E; Misra V; Menon U; Kenner M; Rabinstein AA; Kelley RE; Zivadinov R; Minagar A
Int Rev Neurobiol; 2007; 79():491-519. PubMed ID: 17531856
[TBL] [Abstract][Full Text] [Related]
6. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
8. Role of diffusion-weighted MR in differential diagnosis of intracranial cystic lesions.
Bükte Y; Paksoy Y; Genç E; Uca AU
Clin Radiol; 2005 Mar; 60(3):375-83. PubMed ID: 15710142
[TBL] [Abstract][Full Text] [Related]
9. Dysembryoplastic neuroepithelial tumors: magnetic resonance imaging and magnetic resonance spectroscopy evaluation.
Yu AH; Chen L; Li YJ; Zhang GJ; Li KC; Wang YP
Chin Med J (Engl); 2009 Oct; 122(20):2433-7. PubMed ID: 20079155
[TBL] [Abstract][Full Text] [Related]
10. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
11. Conspicuity of diffuse axonal injury lesions on diffusion-weighted MR imaging.
Kinoshita T; Moritani T; Hiwatashi A; Wang HZ; Shrier DA; Numaguchi Y; Westesson PL
Eur J Radiol; 2005 Oct; 56(1):5-11. PubMed ID: 16168258
[TBL] [Abstract][Full Text] [Related]
12. T2-hyperintense foci on brain MR imaging.
Bekiesińska-Figatowska M
Med Sci Monit; 2004 Jun; 10 Suppl 3():80-7. PubMed ID: 16538206
[TBL] [Abstract][Full Text] [Related]
13. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
[TBL] [Abstract][Full Text] [Related]
14. Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging.
Lee SS; Cha SH; Lee SY; Song CJ
J Comput Assist Tomogr; 2009; 33(2):305-8. PubMed ID: 19346865
[TBL] [Abstract][Full Text] [Related]
15. Paediatric PNET: pre-surgical MRI features.
Chawla A; Emmanuel JV; Seow WT; Lou J; Teo HE; Lim CC
Clin Radiol; 2007 Jan; 62(1):43-52. PubMed ID: 17145263
[TBL] [Abstract][Full Text] [Related]
16. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.
Law M; Meltzer DE; Cha S
Neuroradiology; 2002 Dec; 44(12):986-9. PubMed ID: 12483443
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance features of cerebral malaria.
Yadav P; Sharma R; Kumar S; Kumar U
Acta Radiol; 2008 Jun; 49(5):566-9. PubMed ID: 18568544
[TBL] [Abstract][Full Text] [Related]
18. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Cianfoni A; Niku S; Imbesi SG
AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
[TBL] [Abstract][Full Text] [Related]
19. Role of MRI in the differentiation of ADEM from MS in children.
Callen DJ; Shroff MM; Branson HM; Li DK; Lotze T; Stephens D; Banwell BL
Neurology; 2009 Mar; 72(11):968-73. PubMed ID: 19038851
[TBL] [Abstract][Full Text] [Related]
20. Role of diffusion-weighted magnetic resonance imaging in diffuse axonal injury.
Ezaki Y; Tsutsumi K; Morikawa M; Nagata I
Acta Radiol; 2006 Sep; 47(7):733-40. PubMed ID: 16950714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
